FEATURED PRODUCT
Drug Induced Cardiac Toxicity
Complement in vitro testing to assess drug-induced
proarrhythmic risks in drug candidates early screening.
Pharma
PHARMA
Make your R&D more efficient
through In Silico trials and virtual patients.
More than 95% of molecules will never become a saleable drug either because of safety risks or lack of efficacy. The InSilicoTrials platform enables scientists to unleash the power of modeling and simulation in any stage of drug preclinical and clinical trials, to identify as early as possible the best candidates while assessing their efficacy and safety.
Generate value across the whole R&D process
Main therapeutical areas
Cardiology
Infertility
Neurology
Oncology
Orthopedics
Nefrology